Accelerating the Development of Novel Subcutaneous Drug-Delivery Technologies

Pre-Meeting Workshop

Date/Time: Sunday, July 21, 2019 - 7:30 AM to 11:30 AM
Log in to Add to My Schedule


Subcutaneous delivery has become a critically important drug-delivery method as demand for biotherapeutics requiring complex parenteral drug-delivery has expanded across multiple disease areas. Thus, there is a need for novel subcutaneous delivery technologies that can effectively deliver biotherapeutics. This provides an opportunity for academic and industry stakeholders to jointly focus their efforts towards solving contemporary subcutaneous challenges facing developers. The objective of this workshop is to raise awareness for critical development issues in the subcutaneous industry and collaborate on how to address these hurdles, with a focus on the development of technologies for large-volume and high-dose subcutaneous administration.


7:30 AM – 7:45 AM
Welcome and Introductions
Renee Tannenbaum, Halozyme

7:45 AM – 8:00 AM
Intro to the SC Consortium
Renee Tannenbaum, Halozyme

8:00 AM – 8:45 AM
SC Technology Landscape
Advait Badkar, Pfizer and Randall Mrsny, University Bath

8:45 AM – 9:15 AM
Problem Statements
Manuel Sanchez-Felix, Novartis

9:15 AM – 9:30 AM

9:30 AM – 10:45 AM
Breakout Sessions
SC Consortium Members

10:45 AM – 11:30 AM
Group Discussion
SC Consortium Members

Member organizations of the SC Drug Delivery and Development Consortium include: Alexion Pharmaceuticals, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Halozyme Therapeutics, Merck, Novartis, Pfizer, Regeneron, Roche, Takeda, Teva Pharmaceutical Industries